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Arrhythmogenic Right Ventricular
Cardiomyopathy
An Incomplete Journey*Tal Geva, MDA rrhythmogenic right ventricular cardiomyop-athy (ARVC) is an uncommon inheritedcardiomyopathy characterized by defective
desmosomes, ﬁbrofatty replacement of the right
ventricular (RV) myocardium (and sometimes that
of the left ventricle), abnormal depolarization and
repolarization, ventricular tachyarrhythmia, and
premature death. Since the ﬁrst comprehensive
description of the clinical manifestations of ARVC
by Marcus et al. (1) in 1982, our knowledge of its
genetic causes, pathophysiology, epidemiology, clin-
ical manifestations, and natural history has greatly
improved (2,3). Despite these strides, no single test
is conclusively diagnostic in the disease’s early
stages. Instead, ARVC diagnosis continues to be based
on major and minor criteria derived from imaging
studies, electrophysiology tests, family history, and
histopathology.
Published in 1994, the Task Force Criteria (TFC)
included major and minor abnormities of RV
morphology (localized aneurysms), size, and global
and regional function (4). These abnormalities, how-
ever, were described using qualitative terms with no
objective criteria to distinguish between normal,
mild, and severe anomalies. Notably, fatty inﬁltration
and thinning of the RV free wall, which were thought
to be key cardiac magnetic resonance (CMR) features
of ARVC since the early 1990s (5), were not included*Editorials published in the Journal of the American College of Cardiology
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contents of this paper to disclose.in the 1994 TFC. This exclusion was prescient, as
subsequent studies demonstrated low speciﬁcity and
inconsistent interpretation of fat distribution in
ARVC (6).
The original TFC were revised in 2010 (7). On the
basis of a comparison of 108 probands in the
North American ARVC/D Registry and normal con-
trol subjects (8), the revised Task Force Criteria
(rTFC) included the same 6 categories (imaging,
arrhythmia, depolarization abnormalities, repolariza-
tion abnormalities, family history/genetics, and histo-
pathology). However, several quantitative criteria
replaced qualitative features, and threshold values
were derived to distinguish between minor and major
criteria to maximize speciﬁcity. In the imaging
domain, a ﬁnding of regional RV akinesis, dyskinesis,
or dyssynchronous contraction remained a requisite
subjective criterion; however, objective threshold
values for RV dilation and dysfunction were speciﬁed.
Nearly all published information on ARVC is in
adult patients, which is hardly surprising given that
the disease’s phenotypic expressions usually begin to
manifest in early adulthood. Nonetheless, given the
importance of early detection and the common prac-
tice of screening family members of probands by
imaging, detailed knowledge of the diagnostic per-
formance of noninvasive imaging tests in pediatric
patients referred for evaluation of possible ARVC
is valuable. In this issue of the Journal, Etoom et al.SEE PAGE 987(9) describe their institutional experience with echo-
cardiography and CMR in pediatric patients referred
for assessment of possible ARVC. The authors
analyzed clinical, echocardiographic, CMR, elec-
trocardiographic (ECG), signal average ECG, 24-h
Holter monitor, endomyocardial biopsy, and, when
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997available, genetic test results in 142 patients whose
mean age at imaging was 13.8  3.2 years. Among the
23 patients with deﬁnite disease based on the rTFC,
major CMR criteria were necessary for establishing
the diagnosis in 11 (48%). Notably, only 2 patients met
major echocardiographic criteria and none met minor
criteria.
The ﬁndings of Etoom et al. (9) are a welcome
addition to our knowledge about noninvasive
imaging in young patients with possible ARVC. The
results suggest that there is an important role for
CMR, but not echocardiography, in assessing RV
size, function, and regional wall motion abnormal-
ities (RWMAs) (9). Interestingly, unlike studies in
adults, in whom a large proportion of patients
are diagnosed based on arrhythmia and ECG
criteria, RV abnormalities detected by imaging were
responsible for the diagnosis in most patients in the
study by Etoom et al. (9). This observation contrasts
with ﬁndings of te Riele et al. (10) who followed 69
gene-positive individuals (mean age 27 years) over a
mean period of 5.8 years, during which electrical
abnormalities often preceded imaging-based anoma-
lies. Whether these discrepant ﬁndings can be
explained by referral bias or by actual age-dependent
differences in disease expression requires further
study.
The study by Etoom et al. (9) highlights certain
drawbacks when applying the rTFC imaging criteria
to pediatric patients. First, RWMAs of the RV are
required to satisfy major and minor rTFC imaging
criteria (7). However, diagnosis of RWMAs is sub-
jective. In light of the RV’s complex geometry and
contraction pattern and lack of diagnostic stan-
dardization, it is not surprising that the intra- and
inter-rater reproducibility of diagnosing RWMAs in
the study by Etoom et al. (9) was low (intraobserver
k ¼ 0.57; inter-rater k ¼ 0.40). Moreover, the diag-
nosis of positive RWMAs in 16% of subjects cate-
gorized as “no” ARVC and in 22% categorized as
“possible” ARVC suggests modest speciﬁcity of this
criterion. In contrast, several studies have shown
that the reproducibility of RV volumes and ejection
fraction measurements, the other elements of the
rTFC imaging criteria, is good (11). Second, it is
worth noting that the normative RV data used to
determine the rTFC threshold values were derived
from a study of 462 individuals whose mean age
was 60  10 years (range 45 to 84 years) (12).
Despite adjusting RV volumes to body surface area,
the substantial age discrepancy between the rTFC
normal control subjects and the patients in the
study by Etoom et al. (9) can potentially affect CMRtest characteristics in young individuals. Third, the
normal RV volumes were obtained using a fast
gradient recall echo cine CMR technique, which
yields signiﬁcantly lower values than the currently-
used cine steady-state free-precession technique
(13). This limitation likely affects the utility of the
rTFC RV volume criteria in both children and
adults.
The aforementioned drawbacks of the rTFC imag-
ing criteria can be overcome with reﬁnements based
on newer CMR technology. First, the current subjec-
tive assessment of RV RWMAs should be replaced
with quantitative measures, which will likely reduce
this key criterion’s diagnostic variability. This, for
example, can be accomplished by feature-tracking
CMR, which can be applied to existing standard
cine CMR images, allowing for semiautomatic mea-
surements of RV (and left ventricular) wall displace-
ment, strain, and strain rate (14). Second, the rTFC
threshold values of RV volumes and ejection fractions
should be re-evaluated based on comparison between
a large cohort of ARVC probands with a large group
of age-matched normal control subjects studied
by steady-state free-precession cine CMR. Third,
reﬁning the CMR examination protocol may improve
efﬁciency and allow imagers to focus on the scan’s
clinically important aspects. Speciﬁcally, the utility of
spin-echo imaging deserves critical reassessment
given that evaluation of myocardial fat is not a diag-
nostic criterion for ARVC. In contrast, the role of
imaging ﬁbrosis by late gadolinium enhancement
deserves further study.
Improving the diagnostic utility of noninvasive
imaging in detecting early ARVC manifestations
is an important goal. Although the ﬁndings of
Etoom et al. (9) and others demonstrate a critical
role for CMR, it is imperative to replace criteria
based on old imaging techniques with measures
derived from contemporary methods and to sub-
stitute less reproducible qualitative measures with
reliable quantitative parameters. Finally, explora-
tion of advanced imaging techniques, such as T1
mapping and diffusion tensor imaging by CMR
and 3-dimensional myocardial deformation imaging
by echocardiography, may identify more sensitive
and speciﬁc markers of phenotypic expression
in gene carriers and family members of ARVC
probands.
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